Cato Podcast cover image

Promise and Pitfalls in Taking Psychedelic Medicine Mainstream

Cato Podcast

00:00

Psychedelics

Many drugs that could be useful clinically aren't owned. Big pharma look for something they can derive exclusive revenues from over time. Psychadelic companies have tried to patent various a crystalline latices of silasivon. These are ploys that have been a done by big farma for many years. And an attempt to patent, if they will, essentially unpatentable items.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app